
What We’re Reading: Blood Donation Guidelines Updated; Pfizer CEO Criticizes Drug Price Negotiations; Drug Shortages Worsened
The FDAs newest blood donation guidance may expand donation eligibility; Pfizer CEO anticipates lawsuits to stop US drug price plan; drug shortages have worsened and may increase even with the end of the COVID-19 public health emergency.
FDA Finalizes Blood Donation Guidelines
On Thursday, recommendations for evaluating blood donor eligibility using individual risk-based questions—identical for all potential donors regardless of gender, sex, or sexual orientation—to decrease the risk of transfusion-transmitted HIV were finalized,
Pfizer CEO Criticizes US Drug Price Plan
Albert Bourla, DVM, PhD, CEO of Pfizer Inc, called US agendas to negotiate Medicare drug prices “negotiation with a gun to your head” and said he anticipates drugmakers to sue to stop the process,
Drug Shortages May Increase
COVID-19 curbed the US health care supply chain, but it was going to pieces long before, say experts,
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.